BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9267716)

  • 1. Quality of life of hepatitis B and C patients after liver transplantation.
    Dickson RC; Wright RM; Bacchetta MD; Bodily SE; Caldwell SH; Driscoll CJ; Pruett TL; Ishitani MB
    Clin Transplant; 1997 Aug; 11(4):282-5. PubMed ID: 9267716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved clinical outcomes with liver transplantation for hepatitis B-induced chronic liver failure using passive immunization.
    Sawyer RG; McGory RW; Gaffey MJ; McCullough CC; Shephard BL; Houlgrave CW; Ryan TS; Kuhns M; McNamara A; Caldwell SH; Abdulkareem A; Pruett TL
    Ann Surg; 1998 Jun; 227(6):841-50. PubMed ID: 9637547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization.
    McGory RW; Ishitani MB; Oliveira WM; Stevenson WC; McCullough CS; Dickson RC; Caldwell SH; Pruett TL
    Transplantation; 1996 May; 61(9):1358-64. PubMed ID: 8629297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver transplantation for viral hepatitis: the experience of the hepatobiliary center at Hospital Paul Brousse.
    Samuel D; Feray C; Bismuth H
    Clin Transpl; 1994; ():157-62. PubMed ID: 7547534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevention and treatment of hepatitis B virus reinfection after liver transplantation].
    Liu J; Wu GC; Zhang ZT; Wu P; Zhang D; Sun MC; Gao DC; Wang Y; Jia JD; Wang BE
    Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):976-9. PubMed ID: 16194352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin.
    Terrault NA; Zhou S; Combs C; Hahn JA; Lake JR; Roberts JP; Ascher NL; Wright TL
    Hepatology; 1996 Dec; 24(6):1327-33. PubMed ID: 8938155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleoside plus nucleotide analogs and cessation of hepatitis B immunoglobulin after liver transplantation in chronic hepatitis B is safe and effective.
    Wesdorp DJ; Knoester M; Braat AE; Coenraad MJ; Vossen AC; Claas EC; van Hoek B
    J Clin Virol; 2013 Sep; 58(1):67-73. PubMed ID: 23880162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experiences with liver transplantation in hepatitis B antigen positive liver cirrhosis].
    Steininger R; Mühlbacher F; Längle F; Gnant M; Sautner T; Götzinger P; Walgram M; Penner E; Radaszkiewicz T
    Wien Klin Wochenschr; 1991; 103(19):573-6. PubMed ID: 1759457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of hepatitis B recurrence with indefinite hepatitis B immune globulin (HBIG) prophylaxis after liver transplantation.
    Nymann T; Shokouh-Amiri MH; Vera SR; Riely CA; Alloway RR; Gaber AO
    Clin Transplant; 1996 Dec; 10(6 Pt 2):663-7. PubMed ID: 8996762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of hepatitis B recurrence after liver transplantation using lamivudine and hepatitis B immune globulin.
    Ołdakowska-Jedynak U; Paczek L; Foroncewicz B; Mucha K; Nyckowski P; Zieniewicz K; Ziarkiewicz-Wróblewska B; Ziółkowski J; Pilecki T; Patkowski W; Górnicka B; Paczkowska A; Krawczyk M
    Ann Transplant; 2007; 12(3):28-32. PubMed ID: 18290567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of immune reactivity and pharmacokinetics of two hepatitis B immune globulins in patients after liver transplantation.
    Adler R; Safadi R; Caraco Y; Rowe M; Etzioni A; Ashur Y; Shouval D
    Hepatology; 1999 Apr; 29(4):1299-305. PubMed ID: 10094978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of hepatitis B immunoglobulin in infants born to hepatitis B e antigen-negative carrier mothers in Taiwan.
    Yang YJ; Liu CC; Chen TJ; Lee MF; Chen SH; Shih HH; Chang MH
    Pediatr Infect Dis J; 2003 Jul; 22(7):584-8. PubMed ID: 12867831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prolonged administration of hepatitis B hyperimmune gamma globulin in patients with liver transplantation in liver diseases caused by hepatitis B virus].
    Restrepo JC; Rimola A; Mas A; Navasa M; Salmerón JM; Cirera I; García-Valdecasas JC; Grande L; Visa J; Rodés J
    Gastroenterol Hepatol; 1996 Dec; 19(10):491-6. PubMed ID: 9044746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs and efficacy of "on demand" low-dose immunoprophylaxis in HBV transplanted patients: experience in the Romanian program of liver transplantation.
    Iacob S; Hrehoret D; Matei E; Dorobantu B; Gangone E; Gheorghe L; Popescu I
    J Gastrointestin Liver Dis; 2008 Dec; 17(4):383-8. PubMed ID: 19104697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of liver transplantation in viral hepatitis.
    Pons JA
    J Hepatol; 1995; 22(1 Suppl):146-53. PubMed ID: 7602069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose intramuscular hepatitis B immune globulin and lamivudine for long-term prophylaxis of hepatitis B recurrence after liver transplantation.
    Ferretti G; Merli M; Ginanni Corradini S; Callejon V; Tanzilli P; Masini A; Ferretti S; Iappelli M; Rossi M; Rivanera D; Lilli D; Mancini C; Attili A; Berloco P
    Transplant Proc; 2004 Apr; 36(3):535-8. PubMed ID: 15110584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of entecavir in preventing hepatitis B recurrence after liver transplantation.
    Xi ZF; Xia Q; Zhang JJ; Chen XS; Han LZ; Wang X; Shen CH; Luo Y; Xin TY; Wang SY; Qiu DK
    J Dig Dis; 2009 Nov; 10(4):321-7. PubMed ID: 19906113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational pattern of hepatitis B virus on sequential therapy with famciclovir and lamivudine in patients with hepatitis B virus reinfection occurring under HBIg immunoglobulin after liver transplantation.
    Tillmann HL; Trautwein C; Bock T; Böker KH; Jäckel E; Glowienka M; Oldhafer K; Bruns I; Gauthier J; Condreay LD; Raab HR; Manns MP
    Hepatology; 1999 Jul; 30(1):244-56. PubMed ID: 10385663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of hepatitis B and hepatitis C virus infection on the outcome of kidney transplantation.
    Yuan CH; Liu YF; Li GC
    Chin Med Sci J; 2005 Jun; 20(2):129-32. PubMed ID: 16075755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin.
    Markowitz JS; Martin P; Conrad AJ; Markmann JF; Seu P; Yersiz H; Goss JA; Schmidt P; Pakrasi A; Artinian L; Murray NG; Imagawa DK; Holt C; Goldstein LI; Stribling R; Busuttil RW
    Hepatology; 1998 Aug; 28(2):585-9. PubMed ID: 9696028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.